Dr Abby A Smith, MD | |
323 Lowell St Ste 302, Andover, MA 01810-4501 | |
(978) 475-2731 | |
(978) 975-2536 |
Full Name | Dr Abby A Smith |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 36 Years |
Location | 323 Lowell St Ste 302, Andover, Massachusetts |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1841267390 | NPI | - | NPPES |
006211445 | Medicaid | VA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 273735 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
North Shore Medical Center - | Salem, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
North Shore Physicians Group Inc | 3577467224 | 487 |
News Archive
Fluxion Biosciences, Inc. announced today that the Ohio State University Department of Pharmacology has purchased the IonFlux 16, the first high throughput automated patch clamp instrument of its kind geared towards the academic researcher. The IonFlux instrument will enable large scale pharmacology experiments on this group's nAChR targets, which previously were not feasible using a manual patch clamp rig.
A personal, handheld device emitting high-intensity ultraviolet light to disinfect areas by killing the novel coronavirus is now feasible, according to researchers at Penn State, the University of Minnesota and two Japanese universities.
Diffuse large B-cell lymphoma (DLBCL) is an aggressive cancer and the most frequently diagnosed non-Hodgkin lymphoma worldwide (nearly 40% of cases). Recent advancements indicate that both the prognosis and choice of treatment of DLBCL may depend on identifying its molecular subtype.
A University of Southern California study appearing in the current issue of peer-review journal, Nutrition Research reports that the user-friendly, Web-native Stayhealthy BC1 System offers clinical-grade body composition analysis comparable to the most rigorous clinical tools. According to the company, the study's findings open the door to a new, far more effective and engaging model for health and fitness measurement, reporting body composition analysis, rather than body weight or the outdated body mass index.
› Verified 8 days ago
Entity Name | Andover Obstetrics And Gynecological Associates Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1831304237 PECOS PAC ID: 0345224648 Enrollment ID: O20040615000829 |
News Archive
Fluxion Biosciences, Inc. announced today that the Ohio State University Department of Pharmacology has purchased the IonFlux 16, the first high throughput automated patch clamp instrument of its kind geared towards the academic researcher. The IonFlux instrument will enable large scale pharmacology experiments on this group's nAChR targets, which previously were not feasible using a manual patch clamp rig.
A personal, handheld device emitting high-intensity ultraviolet light to disinfect areas by killing the novel coronavirus is now feasible, according to researchers at Penn State, the University of Minnesota and two Japanese universities.
Diffuse large B-cell lymphoma (DLBCL) is an aggressive cancer and the most frequently diagnosed non-Hodgkin lymphoma worldwide (nearly 40% of cases). Recent advancements indicate that both the prognosis and choice of treatment of DLBCL may depend on identifying its molecular subtype.
A University of Southern California study appearing in the current issue of peer-review journal, Nutrition Research reports that the user-friendly, Web-native Stayhealthy BC1 System offers clinical-grade body composition analysis comparable to the most rigorous clinical tools. According to the company, the study's findings open the door to a new, far more effective and engaging model for health and fitness measurement, reporting body composition analysis, rather than body weight or the outdated body mass index.
› Verified 8 days ago
Entity Name | North Shore Physicians Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1588606123 PECOS PAC ID: 3577467224 Enrollment ID: O20050429000668 |
News Archive
Fluxion Biosciences, Inc. announced today that the Ohio State University Department of Pharmacology has purchased the IonFlux 16, the first high throughput automated patch clamp instrument of its kind geared towards the academic researcher. The IonFlux instrument will enable large scale pharmacology experiments on this group's nAChR targets, which previously were not feasible using a manual patch clamp rig.
A personal, handheld device emitting high-intensity ultraviolet light to disinfect areas by killing the novel coronavirus is now feasible, according to researchers at Penn State, the University of Minnesota and two Japanese universities.
Diffuse large B-cell lymphoma (DLBCL) is an aggressive cancer and the most frequently diagnosed non-Hodgkin lymphoma worldwide (nearly 40% of cases). Recent advancements indicate that both the prognosis and choice of treatment of DLBCL may depend on identifying its molecular subtype.
A University of Southern California study appearing in the current issue of peer-review journal, Nutrition Research reports that the user-friendly, Web-native Stayhealthy BC1 System offers clinical-grade body composition analysis comparable to the most rigorous clinical tools. According to the company, the study's findings open the door to a new, far more effective and engaging model for health and fitness measurement, reporting body composition analysis, rather than body weight or the outdated body mass index.
› Verified 8 days ago
Entity Name | Michael J Grossman Md Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1770530255 PECOS PAC ID: 7517118227 Enrollment ID: O20121106000245 |
News Archive
Fluxion Biosciences, Inc. announced today that the Ohio State University Department of Pharmacology has purchased the IonFlux 16, the first high throughput automated patch clamp instrument of its kind geared towards the academic researcher. The IonFlux instrument will enable large scale pharmacology experiments on this group's nAChR targets, which previously were not feasible using a manual patch clamp rig.
A personal, handheld device emitting high-intensity ultraviolet light to disinfect areas by killing the novel coronavirus is now feasible, according to researchers at Penn State, the University of Minnesota and two Japanese universities.
Diffuse large B-cell lymphoma (DLBCL) is an aggressive cancer and the most frequently diagnosed non-Hodgkin lymphoma worldwide (nearly 40% of cases). Recent advancements indicate that both the prognosis and choice of treatment of DLBCL may depend on identifying its molecular subtype.
A University of Southern California study appearing in the current issue of peer-review journal, Nutrition Research reports that the user-friendly, Web-native Stayhealthy BC1 System offers clinical-grade body composition analysis comparable to the most rigorous clinical tools. According to the company, the study's findings open the door to a new, far more effective and engaging model for health and fitness measurement, reporting body composition analysis, rather than body weight or the outdated body mass index.
› Verified 8 days ago
Entity Name | Obhg Massachusetts Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1740844083 PECOS PAC ID: 6709114556 Enrollment ID: O20190819001315 |
News Archive
Fluxion Biosciences, Inc. announced today that the Ohio State University Department of Pharmacology has purchased the IonFlux 16, the first high throughput automated patch clamp instrument of its kind geared towards the academic researcher. The IonFlux instrument will enable large scale pharmacology experiments on this group's nAChR targets, which previously were not feasible using a manual patch clamp rig.
A personal, handheld device emitting high-intensity ultraviolet light to disinfect areas by killing the novel coronavirus is now feasible, according to researchers at Penn State, the University of Minnesota and two Japanese universities.
Diffuse large B-cell lymphoma (DLBCL) is an aggressive cancer and the most frequently diagnosed non-Hodgkin lymphoma worldwide (nearly 40% of cases). Recent advancements indicate that both the prognosis and choice of treatment of DLBCL may depend on identifying its molecular subtype.
A University of Southern California study appearing in the current issue of peer-review journal, Nutrition Research reports that the user-friendly, Web-native Stayhealthy BC1 System offers clinical-grade body composition analysis comparable to the most rigorous clinical tools. According to the company, the study's findings open the door to a new, far more effective and engaging model for health and fitness measurement, reporting body composition analysis, rather than body weight or the outdated body mass index.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Abby A Smith, MD 323 Lowell St Ste 302, Andover, MA 01810-4501 Ph: (978) 475-2731 | Dr Abby A Smith, MD 323 Lowell St Ste 302, Andover, MA 01810-4501 Ph: (978) 475-2731 |
News Archive
Fluxion Biosciences, Inc. announced today that the Ohio State University Department of Pharmacology has purchased the IonFlux 16, the first high throughput automated patch clamp instrument of its kind geared towards the academic researcher. The IonFlux instrument will enable large scale pharmacology experiments on this group's nAChR targets, which previously were not feasible using a manual patch clamp rig.
A personal, handheld device emitting high-intensity ultraviolet light to disinfect areas by killing the novel coronavirus is now feasible, according to researchers at Penn State, the University of Minnesota and two Japanese universities.
Diffuse large B-cell lymphoma (DLBCL) is an aggressive cancer and the most frequently diagnosed non-Hodgkin lymphoma worldwide (nearly 40% of cases). Recent advancements indicate that both the prognosis and choice of treatment of DLBCL may depend on identifying its molecular subtype.
A University of Southern California study appearing in the current issue of peer-review journal, Nutrition Research reports that the user-friendly, Web-native Stayhealthy BC1 System offers clinical-grade body composition analysis comparable to the most rigorous clinical tools. According to the company, the study's findings open the door to a new, far more effective and engaging model for health and fitness measurement, reporting body composition analysis, rather than body weight or the outdated body mass index.
› Verified 8 days ago
Edwin C Radke, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 140 Haverhill Street, Andover Ob/gyn, Andover, MA 01810 Phone: 978-475-2731 | |
Andrea B Polonsky, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 140 Haverhill St, C/o Andover Ob/gyn, Andover, MA 01810 Phone: 978-475-2731 | |
Elise E Saks, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 140 Haverhill Street, Andover Ob/gyn, Andover, MA 01810 Phone: 978-475-2731 | |
Marie A Drouin, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 60 Wild Rose Dr, Andover, MA 01810 Phone: 978-475-9596 | |
Thomas Edward Davidson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Andover Ob/gyn, 140 Haverhill, Andover, MA 01810 Phone: 978-475-2731 | |
Dr. Sue Yeun Kim, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 140 Hoverhill St, Andover Ob/gyn, Andover, MA 01810 Phone: 978-475-2731 Fax: 978-975-2536 |